USA – Eisai Co Ltd and Eli Lilly and Co have said that they will continue to seek accelerated U.S. approval for experimental Alzheimer’s drugs, despite Medicare’s decision to severely…
Read MoreAlzheimer’s drugmakers seek accelerated FDA review despite limited government coverage
